In 1957, Dr Jean Sterne and his colleagues in France pioneered the treatment of diabetes with the first clinical use of metformin in humans – a moment that truly transformed the management of diabetes.
Glucophage represents the number one oral anti-diabetic brand worldwide by sales and is available in more than 100 countries.
Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. It is sometimes used as an off-label adjunct to lessen the risk of metabolic syndrome in people who take antipsychotics. Metformin is not associated with weight gain and is taken by mouth.